Related references
Note: Only part of the references are listed.Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice
Xueqin Yang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
Alexander Duscha et al.
CELL (2020)
Plasma Short-Chain Fatty Acids in Patients With Parkinson's Disease
Chaewon Shin et al.
MOVEMENT DISORDERS (2020)
Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease
Mihai S. Cirstea et al.
MOVEMENT DISORDERS (2020)
Parkinson disease and the gut: new insights into pathogenesis and clinical relevance
R. Alberto Travagli et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Gut microbial molecules in behavioural and neurodegenerative conditions
Brittany D. Needham et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Individual Dopaminergic Neurons of Lamprey SNc/VTA Project to Both the Striatum and Optic Tectum but Restrict Co-release of Glutamate to Striatum Only
Arndt von Twickel et al.
CURRENT BIOLOGY (2019)
Activation of microglia synergistically enhances neurodegeneration caused by MPP+ in human SH-SY5Y cells
Zhilan Peng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Metabolomics-driven identification of adenosine deaminase as therapeutic target in a mouse model of Parkinson's disease
Wanqiu Huang et al.
JOURNAL OF NEUROCHEMISTRY (2019)
The role of short-chain fatty acids in microbiota-gut-brain communication
Boushra Dalile et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
In vitro colonic fermentation of dietary fibers: Fermentation rate, short-chain fatty acid production and changes in microbiota
Miaomiao Wang et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2019)
Diet and medical foods in Parkinson's disease
Klaus W. Lange et al.
FOOD SCIENCE AND HUMAN WELLNESS (2019)
PBPK/PD assessment for Parkinson's disease risk posed by airborne pesticide paraquat exposure
Yi-Hsien Cheng et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2018)
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLRLI/TNF-α signaling pathway
Meng-Fei Sun et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice
Yosuke Yamawaki et al.
BRAIN RESEARCH (2018)
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease
Valentina Caputi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
International Parkinson and Movement Disorder Society Evidence-Based Medicine Review: Update on Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2018)
Beneficial impacts of Lactobacillus plantarum and inulin on hypothalamic levels of insulin, leptin, and oxidative markers in diabetic rats
Khadijeh Bavafa Valenlia et al.
JOURNAL OF FUNCTIONAL FOODS (2018)
Butyrate: A Double-Edged Sword for Health?
Hu Liu et al.
ADVANCES IN NUTRITION (2018)
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases
Mingming Sun et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage
Isabel Paiva et al.
HUMAN MOLECULAR GENETICS (2017)
Gut microbiota: Implications in Parkinson's disease
Arun Parashar et al.
PARKINSONISM & RELATED DISORDERS (2017)
Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features
Wei Li et al.
SCIENCE CHINA-LIFE SCIENCES (2017)
Neurodegenerative signaling factors and mechanisms in Parkinson's pathology
Poonam Goswami et al.
TOXICOLOGY IN VITRO (2017)
Activation of the HMGB1-RAGE axis upregulates TH expression in dopaminergic neurons via JNK phosphorylation
Soo Jeong Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Sequential Activation of Microglia and Astrocyte Cytokine Expression Precedes Increased Iba-1 or GFAP Immunoreactivity Following Systemic Immune Challenge
Diana M. Norden et al.
GLIA (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
Levodopa therapy for Parkinson disease A look backward and forward
Peter A. LeWitt et al.
NEUROLOGY (2016)
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Marcus M. Unger et al.
PARKINSONISM & RELATED DISORDERS (2016)
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Valeria D. Felice et al.
PARKINSONISM & RELATED DISORDERS (2016)
Methionine Sulfoxide Reductase A Negatively Controls Microglia-Mediated Neuroinflammation via Inhibiting ROS/MAPKs/NF-κB Signaling Pathways Through a Catalytic Antioxidant Function
Hua Fan et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity
Sorabh Sharma et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Nonpharmacological Treatments for Patients with Parkinson's Disease
Bastiaan R. Bloem et al.
MOVEMENT DISORDERS (2015)
Host microbiota constantly control maturation and function of microglia in the CNS
Daniel Erny et al.
NATURE NEUROSCIENCE (2015)
Novel Formulations and Modes of Delivery of Levodopa
Werner Poewe et al.
MOVEMENT DISORDERS (2015)
Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking
James D. Sharer et al.
MOVEMENT DISORDERS (2015)
Altered brain-gut axis in autism: Comorbidity or causative mechanisms?
Emeran A. Mayer et al.
BIOESSAYS (2014)
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Marco Prinz et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Brn4 and TH synergistically promote the differentiation of neural stem cells into dopaminergic neurons
Xuefeng Tan et al.
NEUROSCIENCE LETTERS (2014)
Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms
Maria G. Cersosimo et al.
JOURNAL OF NEUROLOGY (2013)
Short-Chain Fatty Acids Activate AMP-Activated Protein Kinase and Ameliorate Ethanol-Induced Intestinal Barrier Dysfunction in Caco-2 Cell Monolayers
Elhaseen E. Eamin et al.
JOURNAL OF NUTRITION (2013)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
David J. Irwin et al.
NATURE REVIEWS NEUROSCIENCE (2013)
SODIUM BUTYRATE IMPROVES LOCOMOTOR IMPAIRMENT AND EARLY MORTALITY IN A ROTENONE-INDUCED DROSOPHILA MODEL OF PARKINSON'S DISEASE
R. St Laurent et al.
NEUROSCIENCE (2013)
The Monoamine Oxidase Type B Inhibitor Rasagiline in the Treatment of Parkinson Disease: Is Tyramine a Challenge?
Jack J. Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease
D. James Surmeier et al.
CELL CALCIUM (2010)
Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE
Marina O. Ziehn et al.
LABORATORY INVESTIGATION (2010)
Microglial Activation and Chronic Neurodegeneration
Melinda E. Lull et al.
NEUROTHERAPEUTICS (2010)
Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: Further development of a rodent model of autism
Sandy R. Shultz et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
Andis Klegeris et al.
NEUROBIOLOGY OF AGING (2008)
Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
Anamitra Ghosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Prospective study of dietary pattern and risk of Parkinson disease
Xiang Gao et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
P53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain
Makio Mogi et al.
NEUROSCIENCE LETTERS (2007)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
SM Fleming et al.
JOURNAL OF NEUROSCIENCE (2004)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Share Paper
